✦ LIBER ✦

Randomized Phase III Trial of Erlotinib Versus Docetaxel As Second- or Third-Line Therapy in Patients With Advanced Non-Small-Cell Lung Cancer: Docetaxel and Erlotinib Lung Cancer Trial (DELTA)

✍ Scribed by Kawaguchi, T.; Ando, M.; Asami, K.; Okano, Y.; Fukuda, M.; Nakagawa, H.; Ibata, H.; Kozuki, T.; Endo, T.; Tamura, A.; Kamimura, M.; Sakamoto, K.; Yoshimi, M.; Soejima, Y.; Tomizawa, Y.; Isa, S.-i.; Takada, M.; Saka, H.; Kubo, A.

Book ID: 126460198
Publisher: American Society of Clinical Oncology
Year: 2014
Tongue: English
Weight: 183 KB
Volume: 32
Category: Article
ISSN: 0732-183X
DOI: 10.1200/JCO.2013.52.4694

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Docetaxel versus docetaxel plus gemcitab

Docetaxel versus docetaxel plus gemcitabine as front-line treatment of patients with advanced non-small cell lung cancer: A randomized, multicenter phase III trial

✍ Georgoulias, Vassilis; Androulakis, Nikolaos; Kotsakis, Athanasios; Hatzidaki, D 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 239 KB

9001 Vandetanib plus docetaxel versus do

9001 Vandetanib plus docetaxel versus docetaxel as second-line treatment for patients with advanced non-small-cell lung cancer (NSCLC): a randomized, double-blind phase III trial

✍ Eberhardt, W.E.E.; Johnson, B.E.; Sun, Y.; Germonpré, P.; Saijo, N.; Zhou, C.; W 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 49 KB

Erlotinib versus docetaxel as second-lin

Erlotinib versus docetaxel as second-line treatment of patients with advanced non-small-cell lung cancer and wild-type EGFR tumours (TAILOR): a randomised controlled trial

✍ Garassino, Marina Chiara; Martelli, Olga; Broggini, Massimo; Farina, Gabriella; 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 279 KB

PCN25 COST-EFFECTIVENESS ANALYSIS OF ERL

PCN25 COST-EFFECTIVENESS ANALYSIS OF ERLOTINIB VERSUS DOCETAXEL AS A SECOND- OR THIRD-LINE TREATMENT OF NON-SMALL CELL LUNG CANCER IN KOREA

✍ Kim, YG; Lee, EK 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 65 KB

116 Phase III trial of docetaxel plus vi

116 Phase III trial of docetaxel plus vinorelbine in patients with advanced non-small cell lung cancer

✍ Kris, M.G.; Miller, V.A.; Grant, S.C.; Pizzo, B.A.; Early, E.; Martino, D.; Heel 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 300 KB

Randomized Phase II Trial of Onartuzumab

Randomized Phase II Trial of Onartuzumab in Combination With Erlotinib in Patients With Advanced Non-Small-Cell Lung Cancer

✍ Spigel, D. R.; Ervin, T. J.; Ramlau, R. A.; Daniel, D. B.; Goldschmidt, J. H.; B 📂 Article 📅 2013 🏛 American Society of Clinical Oncology 🌐 English ⚖ 266 KB